Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Sep 5;89(17):8892-8900.
doi: 10.1021/acs.analchem.7b01358. Epub 2017 Aug 17.

An LC-MS/MS-Based Method for the Quantification of Pyridox(am)ine 5'-Phosphate Oxidase Activity in Dried Blood Spots from Patients with Epilepsy

Affiliations

An LC-MS/MS-Based Method for the Quantification of Pyridox(am)ine 5'-Phosphate Oxidase Activity in Dried Blood Spots from Patients with Epilepsy

Matthew P Wilson et al. Anal Chem. .

Abstract

We report the development of a rapid, simple, and robust LC-MS/MS-based enzyme assay using dried blood spots (DBS) for the diagnosis of pyridox(am)ine 5'-phosphate oxidase (PNPO) deficiency (OMIM 610090). PNPO deficiency leads to potentially fatal early infantile epileptic encephalopathy, severe developmental delay, and other features of neurological dysfunction. However, upon prompt treatment with high doses of vitamin B6, affected patients can have a normal developmental outcome. Prognosis of these patients is therefore reliant upon a rapid diagnosis. PNPO activity was quantified by measuring pyridoxal 5'-phosphate (PLP) concentrations in a DBS before and after a 30 min incubation with pyridoxine 5'-phosphate (PNP). Samples from 18 PNPO deficient patients (1 day-25 years), 13 children with other seizure disorders receiving B6 supplementation (1 month-16 years), and 37 child hospital controls (5 days-15 years) were analyzed. DBS from the PNPO-deficient samples showed enzyme activity levels lower than all samples from these two other groups as well as seven adult controls; no false positives or negatives were identified. The method was fully validated and is suitable for translation into the clinical diagnostic arena.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Figure 1
Figure 1
Vitamin B6 metabolism. (a) Pyridoxine, (b) pyridoxal, (c) pyridoxamine, (d) pyridoxine 5′-phosphate, (e) pyridoxal 5′-phosphate, and (f) pyridoxamine 5′-phosphate. PK = pyridoxal kinase; PNPO = pyridox(am)ine 5′-phosphate oxidase.
Figure 2
Figure 2
Effect of humidity on the short-term stability of the PNPO enzyme in dried blood spots. Error bars indicate SEM. DBS were stored in sealed foil bags with desiccant (▲) or under ambient conditions (■) at room temperature (22 °C). Data points represent the mean percentage of activity as compared to that found after 1 day (n = 2).
Figure 3
Figure 3
Effect of temperature (4 °C [●], −20 °C [■], and −80 °C [▲]) on the long-term stability of the PNPO enzyme in dried blood spots (DBS). Data points represent the mean percentage of PNPO activity relative to measurement at time zero. Error bars indicate SEM. No significant difference was seen in activities of samples with/without desiccant; the data from DBS stored both with (n = 2) and without (n = 2) desiccant at each temperature have therefore been combined (n = 4).
Figure 4
Figure 4
DBS PNPO enzyme activity in PNPO-deficient patients and control samples. Box plots indicate range, interquartile range, and median. Statistical analysis was performed using one-way ANOVA followed by Tukey’s multiple comparisons test; ** = P < 0.01; **** = P < 0.0001.

References

    1. Clayton P. T. J. Inherited Metab. Dis. 2006, 29, 317–326. 10.1007/s10545-005-0243-2. - DOI - PubMed
    1. Mills P. B.; Camuzeaux S. S.; Footitt E. J.; Mills K. A.; Gissen P.; Fisher L.; Das K. B.; Varadkar S. M.; Zuberi S.; McWilliam R.; Stodberg T.; Plecko B.; Baumgartner M. R.; Maier O.; Calvert S.; Riney K.; Wolf N. I.; Livingston J. H.; Bala P.; Morel C. F.; Feillet F.; Raimondi F.; Del Giudice E.; Chong W. K.; Pitt M.; Clayton P. T. Brain 2014, 137, 1350–1360. 10.1093/brain/awu051. - DOI - PMC - PubMed
    1. Plecko B.; Paul K.; Mills P.; Clayton P.; Paschke E.; Maier O.; Hasselmann O.; Schmiedel G.; Kanz S.; Connolly M.; Wolf N.; Struys E.; Stockler S.; Abela L.; Hofer D. Neurology 2014, 82, 1425–1433. 10.1212/WNL.0000000000000344. - DOI - PMC - PubMed
    1. Mackey A. D.; McMahon R. J.; Townsend J. H.; Gregory J. F. III. J. Nutr. 2004, 134, 842–846. - PubMed
    1. Mills P. B.; Surtees R. A.; Champion M. P.; Beesley C. E.; Dalton N.; Scambler P. J.; Heales S. J.; Briddon A.; Scheimberg I.; Hoffmann G. F.; Zschocke J.; Clayton P. T. Hum. Mol. Genet. 2005, 14, 1077–1086. 10.1093/hmg/ddi120. - DOI - PubMed

Publication types

MeSH terms